Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ferme, C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 29 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Guermazi, A; Brice, P; de Kerviler, E; Ferme, C; Hennequin, C; Meignin, V; Frija, J
      Extranodal Hodgkin disease: Spectrum of disease

      RADIOGRAPHICS
    2. Brice, P; Colin, P; Berger, F; de Kerviler, E; Divine, M; Bouaffia, F; Kerneis, Y; Blanc, M; Lepage, E; Ferme, C
      Advanced Hodgkin disease with large mediastinal involvement can be treatedwith eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy - A study of 82 patients from the groupes d'Etudes des Lymphomes de ''adulte H89 Trial

      CANCER
    3. Ferme, C; Cosset, JM; Fervers, B; Sebban, C; Cutuli, B; Henry-Amar, M; Stines, J; Giammarile, F; Bey, P; Carella, AM; Philip, T
      Hodgkins disease

      BRITISH JOURNAL OF CANCER
    4. Camilleri-Broet, S; Audouin, J; Ferme, C; Briere, J; Pulford, K; Gaulard, P; Divine, M; Macintyre, E; Delsol, G; Berger, F
      ALK is not expressed in Hodgkin disease

      BLOOD
    5. Ferme, C; Sebban, C; Hennequin, C; Divine, M; Lederlin, P; Gabarre, J; Ferrant, A; Caillot, D; Bordessoule, D; Brice, P; Moullet, I; Berger, F; Lepage, E
      Comparison of chemotherapy to radiotherapy as consolidation of complete orgood partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial

      BLOOD
    6. Brice, P; Divine, M; Simon, D; Coiffier, B; Leblond, V; Simon, M; Voilat, L; Devidas, A; Morschhauser, F; Rohrlich, P; Andre, M; Lepage, E; Ferme, C
      Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)

      ANNALS OF ONCOLOGY
    7. Ferme, C; Cosset, JM; Fervers, B; Sebban, C; Cutuli, B; Henry-Amar, M; Stines, J; Giammarile, F; Bey, P; Carella, AM; Philip, T
      Standards, options and recommendations for the management of patients withHodgkin's disease

      PRESSE MEDICALE
    8. Fitoussi, O; Simon, D; Brice, P; Makke, J; Scrobohaci, ML; Triki, TB; Hennequin, C; Ferme, C; Gisselbrecht, C
      Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma

      BONE MARROW TRANSPLANTATION
    9. Flechtner, H; Ruffer, JU; Henry-Amar, M; Mellink, WAM; Sieber, M; Ferme, C; Eghbali, H; Josting, A; Diehl, V
      Quality of life assessment in Hodgkin's disease: A new comprehensive approach - First experiences from the EORTC/GELA and GHSG trials

      ANNALS OF ONCOLOGY
    10. MOREAU P; FLEURY J; BRICE P; COLOMBAT P; BOUABDALLAH R; LIOURE B; VOILLAT L; CASASNOVAS O; FRANCOIS S; SADOUN A; LAMY T; LOTZ JP; MUNCK JN; DIVINE M; FERME C; PENY AM; FRUCHART C; ORIOL P; OJEDA M; REMAN O; MILPIED N; GISSELBRECHT C; LEGROS M; HAROUSSEAU JL
      EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY

      Bone marrow transplantation
    11. BRICE P; DIVINE M; COIFFIER B; LEBLOND V; SIMON M; DEVIDAS A; SIMON D; ROHRLICH P; FERME C
      DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN REFRACTORY AND EARLY DISSEMINATED RELAPSE FROM HODGKINS-DISEASE (HD) - A PILOT-STUDY FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE/

      Bone marrow transplantation
    12. ANDRE M; HENRYAMAR M; BLAISE D; COLOMBAT P; FLEURY J; MILPIED N; CAHN JY; PICO JL; BASTION Y; KUENTZ M; NEDELLEC G; ATTAL M; FERME C; GISSELBRECHT C
      TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE

      Blood
    13. ANDRE M; BRICE P; CAZALS D; HENNEQUIN C; FERME C; KERNEIS Y; ROUSSELOT P; ZINI JM; LEPAGE E; GISSELBRECHT C
      RESULTS OF 3 COURSES OF ADRIAMYCIN, BLEOMYCIN, VINDESINE, AND DACARBAZINE WITH SUBTOTAL NODAL IRRADIATION IN 189 PATIENTS WITH NODAL HODGKINS-DISEASE (STAGE-I, STAGE-II AND STAGE-IIIA)

      HEMATOLOGY AND CELL THERAPY
    14. GILLETTE JF; FERME C; MOISY N; MIGNOT L; SCHACH R; VIGNAUX JR; BESNER JG; CAILLE G; BELPOMME D
      DOUBLE-BLIND CROSSOVER CLINICAL AND PHARMACOKINETIC COMPARISON OF ORAL MORPHINE SYRUP AND SUSTAINED-RELEASE MORPHINE-SULFATE CAPSULES IN PATIENTS WITH CANCER-RELATED PAIN

      Clinical drug investigation
    15. FERME C
      HODGKINS-DISEASE - CURRENT ASPECTS

      La Presse medicale
    16. FERME C; BASTION Y; BRICE P; LEDERLIN P; DIVINE M; GABARRE J; ASSOULINE D; FERRANT A; BERGER F; LEPAGE E
      PROGNOSIS OF PATIENTS WITH ADVANCED HODGKINS-DISEASE - EVALUATION OF 4 PROGNOSTIC MODELS USING 344 PATIENTS INCLUDED IN THE GROUP-DETUDES-DES-LYMPHOMES-DE-LADULTE STUDY

      Cancer
    17. GUERMAZI A; FERME C; DEKERVILER E; FRIJA J; BRICE P
      DOES LYMPHANGIOGRAPHY STILL HAVE A PLACE IN THE STAGING OF HODGKIN DISEASE

      Radiology
    18. BRICE P; BASTION Y; DIVINE M; NEDELLEC G; FERRANT A; GABARRE J; REMAN O; LEPAGE E; FERME C
      ANALYSIS OF PROGNOSTIC FACTORS AFTER THE FIRST RELAPSE OF HODGKINS-DISEASE IN 187 PATIENTS

      Cancer
    19. ANDRE M; HENRYAMAR M; PICO JL; BASTION Y; BLAISE D; KUENTZ M; COLOMBAT P; CAHN JY; ATTAL M; FLEURY J; MILPIED N; BIRON P; NEDELLEC G; JOUET JP; TILLY R; FERME C; GISSELBRECHT C
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY

      Blood
    20. MOREAU P; FLEURY J; BOUABDALLAH R; COLOMBAT P; BRICE P; LIOURE B; VOILLAT L; SADOUN A; FRANCOIS S; LAMY T; CASASNOVAS O; LINASSIER C; LEGROS M; MILPIED N; BASTION Y; BIRON P; ANDRE M; DIVINE M; FERME C; JOUET JP; HAROUSSEAU JL
      EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN HIGH-RISK HODGKINS-DISEASE (HD) - REPORT OF 158 CASES FROM THE FRENCH REGISTRY (SFGM)

      Blood
    21. GISSELBRECHT C; FERME C
      PROGNOSTIC FACTORS IN ADVANCED HODGKINS-DISEASE - PROBLEMS AND PITFALLS - TOWARDS AN INTERNATIONAL PROGNOSTIC INDEX

      Leukemia & lymphoma
    22. FERME C; BASTION Y; LEPAGE E; BERGER F; BRICE P; MOREL P; GABARRE J; NEDELLEC G; REMAN O; CHERON N; OBERLIN O; COIFFIER B
      THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE

      Annals of oncology
    23. ANDRE M; HENRYAMAR M; BLAISE D; COLOMBAT P; FLEURY J; MILPIED N; GAHN JY; PICO JL; BASTION Y; KUENTZ M; BIRON P; FERME C; GISSELBRECHT C
      INCIDENCE OF 2ND CANCERS (SC) AND CAUSES OF DEATH AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HODGKINS-DISEASE (HD)

      Blood
    24. ANDRIVET P; BACQUER A; NGOC CV; FERME C; LETINIER JY; GAUTIER H; GALLET CB; BRUNBUISSON C
      LACK OF CLINICAL BENEFIT FROM SUBCUTANEOUS TUNNEL INSERTION OF CENTRAL VENOUS CATHETERS IN IMMUNOCOMPROMISED PATIENTS

      Clinical infectious diseases
    25. TREDANIEL J; PEILLON I; FERME C; BRICE P; GISSELBRECHT C; HIRSCH A
      ENDOBRONCHIAL PRESENTATION OF HODGKINS-DISEASE - A REPORT OF 9 CASES AND REVIEW OF THE LITERATURE

      The European respiratory journal
    26. FERME C; HENRYAMAR M
      HODGKINS-DISEASE MANAGEMENT AND FOLLOW-UP REVISITED

      Nouvelle revue francaise d'hematologie
    27. FERME C; BRICE P; GABARRE J; DIVINE M; DETOURMIGNIES L; JAUBERT J; CAILLOT D; BASTION Y; ASSOULINE D; NEDELLEC G; ISNARD F; TABAH I
      MINE CHEMOTHERAPY PLUS RHGM-CSF AS SALVAGE AND PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZING REGIMEN FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE (HD)

      Blood
    28. FERME C; LEPAGE E; BRICE P; DAGAY MF; FERMAND JP; CASTAIGNE S; FRIJA J; MIOT C; MARTY M; GISSELBRECHT C
      COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS

      International journal of radiation oncology, biology, physics
    29. BRICE P; RAIN JD; FRIJA J; MIAUX Y; MAROLLEAU JP; TREDANIEL J; FERME C; HENNEQUIN C; GISSELBRECHT C
      RESIDUAL MEDIASTINAL MASS IN MALIGNANT-LYMPHOMA - VALUE OF MAGNETIC-RESONANCE-IMAGING AND GALLIUM SCAN

      Nouvelle revue francaise d'hematologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 10:23:35